WV HB3434

Amends West Virginia's controlled substance schedules (Schedules I-V) under Article 2 of Chapter 60A of the state code to update and correct errors in the drug classification lists

Adds multiple synthetic opioids to Schedule I, including various nitazene compounds (butonitazene, etodesnitazene, flunitazene, metonitazene, protonitazene, isotonitazene), synthetic cannabinoids, and designer benzodiazepines (bromazolam, clonazolam, etizolam, flualprazolam)

Updates Schedule II to include additional opiates such as norfentanyl, oliceridine, and thiafentanil, along with the fentanyl precursor 4-anilino-N-phenethyl-4-piperidine (ANPP)

Adds new substances to Schedules III-V including perampanel (Schedule III), xylazine, daridorexant, lemborexant, remimazolam, and zuranolone (Schedule IV), and ganaxolone, cenobamate, and lasmiditan (Schedule V)

Effective 90 days from passage (July 10, 2025), requested by the West Virginia Department of Homeland Security through the West Virginia State Police